The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia

H3K27me3去甲基化酶UTX是T细胞急性淋巴细胞白血病中的一种性别特异性肿瘤抑制因子。

阅读:3
作者:Joni Van der Meulen,Viraj Sanghvi,Konstantinos Mavrakis,Kaat Durinck,Fang Fang,Filip Matthijssens,Pieter Rondou,Monica Rosen,Tim Pieters,Peter Vandenberghe,Eric Delabesse,Tim Lammens,Barbara De Moerloose,Björn Menten,Nadine Van Roy,Bruno Verhasselt,Bruce Poppe,Yves Benoit,Tom Taghon,Ari M Melnick,Frank Speleman,Hans-Guido Wendel,Pieter Van Vlierberghe

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive form of leukemia that is mainly diagnosed in children and shows a skewed gender distribution toward males. In this study, we report somatic loss-of-function mutations in the X-linked histone H3K27me3 demethylase ubiquitously transcribed X (UTX) chromosome, in human T-ALL. Interestingly, UTX mutations were exclusively present in male T-ALL patients and allelic expression analysis revealed that UTX escapes X-inactivation in female T-ALL lymphoblasts and normal T cells. Notably, we demonstrate in vitro and in vivo that the H3K27me3 demethylase UTX functions as a bona fide tumor suppressor in T-ALL. Moreover, T-ALL driven by UTX inactivation exhibits collateral sensitivity to pharmacologic H3K27me3 inhibition. All together, our results show how a gender-specific and therapeutically relevant defect in balancing H3K27 methylation contributes to T-cell leukemogenesis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。